Vbi Vaccines, Inc.盘中异动快速拉升5.97%报0.131美元

自选股智能写手07-31

北京时间2024年07月31日21时31分，Vbi Vaccines, Inc.（VBIV.us）股票出现波动，股价急速拉升5.97%。截至发稿，该股报0.131美元/股，成交量530.679万股，换手率18.50%，振幅6.29%。最近的财报数据显示，该股实现营业收入1.21百万美元，净利润-17.90百万美元，每股收益-0.73美元，毛利-2.00百万美元，市盈率-0.04倍。机构评级方面，在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2455139740?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-31 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2455139740","market":"us","top_or_hot":-1,"title":"Vbi Vaccines, Inc.盘中异动 快速拉升5.97%报0.131美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年07月31日21时31分，Vbi Vaccines, Inc.（VBIV.us）股票出现波动，股价急速拉升5.97%。截至发稿，该股报0.131美元/股，成交量530.679万股，换手率18.50%，振幅6.29%。最近的财报数据显示，该股实现营业收入1.21百万美元，净利润-17.90百万美元，每股收益-0.73美元，毛利-2.00百万美元，市盈率-0.04倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312131589f022df4&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vbi Vaccines, Inc.盘中异动 快速拉升5.97%报0.131美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVbi Vaccines, Inc.盘中异动 快速拉升5.97%报0.131美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-31 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312131589f022df4&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年07月31日21时31分，Vbi Vaccines, Inc.（VBIV.us）股票出现波动，股价急速拉升5.97%。截至发稿，该股报0.131美元/股，成交量530.679万股，换手率18.50%，振幅6.29%。最近的财报数据显示，该股实现营业收入1.21百万美元，净利润-17.90百万美元，每股收益-0.73美元，毛利-2.00百万美元，市盈率-0.04倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312131589f022df4&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VBIV","symbol_name":"VBI Vaccines Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312131589f022df4&s=b","article_id":"2455139740","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312131589f022df4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2455139740","pubTimestamp":1722432717,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年07月31日21时31分，Vbi Vaccines, Inc.股票出现波动，股价急速拉升5.97%。Vbi Vaccines, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Vbi Vaccines, Inc.公司简介：VBI Vaccines Inc 是一家商业化阶段的生物制药公司，致力于开发新一代疫苗，以满足传染病和免疫肿瘤学领域尚未得到满足的需求。消息层面，截至21时31分，《腾盛博药：合作伙伴VBI已启动重组程序》资讯为影响Vbi Vaccines, Inc.的重要信息。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"VBIV":"VBI Vaccines Inc.","BK4139":"生物科技"},"translate_title":"Vbi Vaccines, Inc. quickly rose 5.97% to $0.131 after intraday movements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VBIV":0.9},"content_text":"北京时间2024年07月31日21时31分，Vbi Vaccines, Inc.（VBIV.us）股票出现波动，股价急速拉升5.97%。截至发稿，该股报0.131美元/股，成交量530.679万股，换手率18.50%，振幅6.29%。最近的财报数据显示，该股实现营业收入1.21百万美元，净利润-17.90百万美元，每股收益-0.73美元，毛利-2.00百万美元，市盈率-0.04倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Vbi Vaccines, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Zevra Therapeutics, Inc.、Adial Pharmaceuticals, Inc、Engene Holdings Inc C/Wts 31/10/2028 (To Pur Com) Cl A涨幅较大，Bionomics Ltd Ads Each Rep 180 Ord Shs、Imunon, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为111.70%、47.81%、33.95%，振幅较大的相关个股有Vaccinex, Inc.、Zevra Therapeutics, Inc.、Renovaro Inc.，振幅分别为12.28%、10.36%、9.61%。Vbi Vaccines, Inc.公司简介：VBI Vaccines Inc 是一家商业化阶段的生物制药公司，致力于开发新一代疫苗，以满足传染病和免疫肿瘤学领域尚未得到满足的需求。该公司生产的 Sci-B-Vac 产品是用于成人，儿童和新生儿的乙型肝炎 (HBV) 疫苗。公司的产品包括病毒样颗粒疫苗，这是一个疫苗平台，可以设计出与目标病毒近似的包膜病毒样颗粒疫苗。该公司通过单一部门进行运营开发疫苗来解决传染病和免疫肿瘤学方面未满足的需求。消息层面，截至21时31分，《腾盛博药：合作伙伴VBI已启动重组程序》资讯为影响Vbi Vaccines, Inc.的重要信息。该信息摘要如下：腾盛博药-B7月31日在港交所公告称，合作伙伴VBI Vaccines Inc.已根据经修订的《公司债权人安排法》启动重组程序；预计VBI的破产对公司运营及财务状况影响甚微。公司依然拥有于 2023年7月6日获得的BRII-179全球独家许可及PreHevbri亚太地区（日本除外）权益，并已为所有计划中涉及BRII-179的临床研究确保了临床供应。此外，参见本公司2024年2月14日的公告，本公司自2024年2月起一直与VBI密切合作，计划将BRII-179的生产责任转移给第三方合同开发和制造商，目前该计划在继续实施中。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2455139740"}

Vbi Vaccines, Inc.盘中异动 快速拉升5.97%报0.131美元

精彩评论

Vbi Vaccines, Inc.盘中异动快速拉升5.97%报0.131美元